Robert Thomas Freeman Sells 21,375 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 21,375 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $10.66, for a total value of $227,857.50. Following the completion of the transaction, the chief financial officer now owns 243,054 shares in the company, valued at approximately $2,590,955.64. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Robert Thomas Freeman also recently made the following trade(s):

• On Friday, September 13th, Robert Thomas Freeman sold 14,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $12.00, for a total value of $174,000.00.
• On Wednesday, September 11th, Robert Thomas Freeman sold 8,561 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $85,695.61.
• On Wednesday, September 4th, Robert Thomas Freeman sold 1,650 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $16,500.00.
• On Friday, July 19th, Robert Thomas Freeman sold 38,858 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $388,968.58.
• On Wednesday, July 17th, Robert Thomas Freeman sold 22,100 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.00, for a total value of $221,000.00.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $10.92 on Friday. The company has a debt-to-equity ratio of 1.70, a current ratio of 1.61 and a quick ratio of 1.61. The business has a fifty day simple moving average of $9.73 and a two-hundred day simple moving average of $7.84. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $12.36. The company has a market capitalization of $2.09 billion, a P/E ratio of -13.00 and a beta of 1.47.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, August 1st. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.01. Alignment Healthcare had a negative return on equity of 101.10% and a negative net margin of 6.85%. The business had revenue of $681.29 million during the quarter, compared to the consensus estimate of $637.66 million. During the same period last year, the business posted ($0.15) earnings per share. The business’s revenue for the quarter was up 47.3% on a year-over-year basis. On average, analysts expect that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on ALHC. TD Cowen raised their target price on Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a report on Tuesday, August 6th. Piper Sandler restated an “overweight” rating and issued a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. Stifel Nicolaus increased their price target on Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Barclays increased their price target on Alignment Healthcare from $4.50 to $7.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Finally, Robert W. Baird increased their price target on Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a research report on Wednesday, August 14th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $9.83.

Institutional Trading of Alignment Healthcare

A number of large investors have recently bought and sold shares of ALHC. Allspring Global Investments Holdings LLC increased its position in Alignment Healthcare by 9.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock worth $196,000 after buying an additional 3,334 shares during the last quarter. Principal Financial Group Inc. purchased a new position in shares of Alignment Healthcare in the first quarter valued at $57,000. Blue Trust Inc. grew its position in shares of Alignment Healthcare by 47.4% in the first quarter. Blue Trust Inc. now owns 256,452 shares of the company’s stock valued at $1,272,000 after purchasing an additional 82,476 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Alignment Healthcare by 1.0% in the first quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock valued at $45,828,000 after purchasing an additional 93,262 shares in the last quarter. Finally, Hood River Capital Management LLC grew its position in shares of Alignment Healthcare by 49.6% in the first quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock valued at $14,487,000 after purchasing an additional 968,637 shares in the last quarter. 86.19% of the stock is owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.